article thumbnail

Understanding Large Molecule Drug Development: From Biologics to Market

Syner-G

billion by 2028. Both processes are evolving to enhance product development and output. Upstream processing advancements encompass fed-batch processes , improved cell culture media, advanced feeding strategies, and tailored bioreactor control.